These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21456391)

  • 1. Are we ready for neoadjuvant therapy in potentially resectable pancreatic cancer?
    Philip PA
    Oncology (Williston Park); 2011 Feb; 25(2):189-90, 192. PubMed ID: 21456391
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant and neoadjuvant therapy for pancreatic cancer.
    Vinciguerra V
    Oncology (Williston Park); 2011 Feb; 25(2):192-3. PubMed ID: 21456392
    [No Abstract]   [Full Text] [Related]  

  • 3. A neoadjuvant strategy for the management of nonmetastatic pancreatic cancer.
    Goff SL; Chabot JA
    Cancer J; 2012; 18(6):602-8. PubMed ID: 23187848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New developments in the management of borderline resectable pancreatic cancers.
    Goodman MD; McPartland S; Huber K; Saif MW
    JOP; 2013 Jul; 14(4):334-6. PubMed ID: 23846921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary trials evaluating neoadjuvant therapy for resectable pancreatic cancer.
    Chawla A
    J Surg Oncol; 2021 May; 123(6):1423-1431. PubMed ID: 33831254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neoadjuvant chemotherapy for resectable pancreatic cancer].
    Unno M
    Nihon Shokakibyo Gakkai Zasshi; 2020; 117(4):297-301. PubMed ID: 32281569
    [No Abstract]   [Full Text] [Related]  

  • 7. [Efficacy of neoadjuvant chemotherapy for resectable pancreatic carcinoma].
    Motoi F; Kawaguchi K; Aoki T; Kudo K; Yabuuchi S; Fukase K; Mizuma M; Sakata N; Otsutomo S; Morikawa T; Hayashi H; Nakagawa K; Okada T; Yoshida H; Naitoh T; Katayose Y; Egawa S; Unno M
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1632-6. PubMed ID: 24393872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant and neoadjuvant approaches to treat surgically resectable pancreatic cancer.
    Keedy VL; Berlin J
    Curr Treat Options Oncol; 2006 Sep; 7(5):381-8. PubMed ID: 16904055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of radiation therapy in patients with resectable pancreatic cancer.
    Palta M; Willett C; Czito B
    Oncology (Williston Park); 2011 Jul; 25(8):715-21, 727. PubMed ID: 21874833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Postoperative adjuvant chemotherapy for resectable pancreatic cancer].
    Uesaka K
    Nihon Shokakibyo Gakkai Zasshi; 2020; 117(4):308-312. PubMed ID: 32281571
    [No Abstract]   [Full Text] [Related]  

  • 11. [Developments and controversies in neoadjuvant therapy for resectable pancreatic cancer].
    Bai XL; Li X; Liang TB
    Zhonghua Wai Ke Za Zhi; 2020 Jul; 58(7):486-489. PubMed ID: 32610415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative Therapy for Borderline Resectable Pancreatic Cancer: What and When?
    Kim MP; Katz MHG
    Ann Surg Oncol; 2019 Jun; 26(6):1596-1597. PubMed ID: 30680479
    [No Abstract]   [Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy for localized pancreatic cancer: too little or too long?
    White RR; Evans DB
    Ann Surg Oncol; 2014 May; 21(5):1508-9. PubMed ID: 24452411
    [No Abstract]   [Full Text] [Related]  

  • 14. Status of neoadjuvant therapy for resectable pancreatic cancer.
    Hoffman JP
    Surg Oncol Clin N Am; 2010 Apr; 19(2):411-8. PubMed ID: 20159522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant Radiation Therapy Should Still Be Considered in Select Patients With Borderline Resectable Pancreas Cancer.
    Herman JM
    Int J Radiat Oncol Biol Phys; 2023 Jul; 116(4):709. PubMed ID: 37355307
    [No Abstract]   [Full Text] [Related]  

  • 16. [Future concepts for neoadjuvant and adjuvant treatment of (resectable) pancreatic cancer].
    Seufferlein T; Michalski C
    Chirurg; 2022 May; 93(5):441-445. PubMed ID: 35376964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of preoperative combined radiation therapy and chemotherapy with 5-fluorouracil and cisplatin in potentially resectable pancreatic adenocarcinoma: The French SFRO-FFCD 97-04 Phase II trial.
    Mornex F; Girard N; Scoazec JY; Bossard N; Ychou M; Smith D; Seitz JF; Valette PJ; Roy P; Rouanet P; Ducreux M; Partensky C
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1471-8. PubMed ID: 16793214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant chemotherapy in resectable pancreatic cancer.
    Irmscher S; Senninger N; Schleicher C
    Ann Surg Oncol; 2008 Jul; 15(7):2059-60; author reply 2061. PubMed ID: 18266042
    [No Abstract]   [Full Text] [Related]  

  • 19. Neoadjuvant mFOLFIRINOX vs mFOLFIRINOX Plus Radiotherapy in Patients With Borderline Resectable Pancreatic Cancer-The A021501 Trial.
    Hintz B; Lee VJ
    JAMA Oncol; 2023 Feb; 9(2):277. PubMed ID: 36454584
    [No Abstract]   [Full Text] [Related]  

  • 20. Neoadjuvant mFOLFIRINOX vs mFOLFIRINOX Plus Radiotherapy in Patients With Borderline Resectable Pancreatic Cancer-The A021501 Trial.
    Grossberg AJ; Jethwa KR; Ellsworth SG
    JAMA Oncol; 2023 Feb; 9(2):275. PubMed ID: 36454560
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.